Trexquant Investment LP - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,325,304
+33.4%
51,871
+49.7%
0.03%
+26.9%
Q2 2023$993,504
+175.2%
34,641
+62.8%
0.03%
+160.0%
Q4 2022$360,977
+64.1%
21,284
+258.4%
0.01%
-28.6%
Q4 2021$220,000
-1.8%
5,939
+9.4%
0.01%
-33.3%
Q1 2021$224,000
+30.2%
5,428
-57.0%
0.02%
+75.0%
Q1 2020$172,00012,6320.01%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders